Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
Go back to Holmes Biopharma, Inc. (LMB) Reports Q2 EPS of $0.09, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 51.74 +1.69 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.05 | 52 Week High | $0.15 | |||
| Open | $49.68 | 52 Week Low | $0.15 | |||
| Day High | $52.43 | P/E | N/A | |||
| Day Low | $49.58 | EPS | $0.00 | |||
| Volume | 511,665 | |||||
